Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Rising Cancer Diagnoses in Young Adults: Lifestyle Changes and Early Screenings can Lower Risks

Cancer diagnoses among young adults are rising, driven by environmental, behavioral, and genetic factors. Host Kevin Stevenson and Dr. Najeeb Al Hallak discuss the importance of early screenings—such as colonoscopies, mammograms, and genetic testing—in detecting cancer sooner in younger populations. Primary care physicians are identified as critical players in early detection and prevention efforts.

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from I Don't Care on MarketScale.

By Kevin Stevenson · Barbara Ann Karmanos Cancer InstituteCancer DetectionCancer PreventionDr. Najeeb Al Hallak
Share

Key takeaways

01

Cancer is increasingly being diagnosed in younger adults, making early screening more critical than ever.

02

Environmental and behavioral factors, alongside genetics, are contributing to the rise in early-onset cancers.

03

Primary care physicians play a pivotal role in recommending timely screenings such as colonoscopies, mammograms, and genetic tests.

Get featured

Want MarketScale to feature Healthcare?

Book a 15-minute demo and we'll map your Healthcare expertise to the content buyers are searching for.

Book a demo

In recent years, a troubling trend has emerged: a noticeable rise in cancer diagnoses among young adults. This discussion is particularly timely following the news of Princess Kate Middleton’s cancer diagnosis and the growing recognition that cancer is no longer a disease confined to older populations. Research indicates that environmental and behavioral factors, alongside genetics, may be contributing to this increase.

Cancer is no longer a disease confined to older populations.

Why is there an increase in cancer diagnoses among younger populations, and what screenings should be prioritized to detect it early?

In this episode of “I Don’t Care,” host Dr. Kevin Stevenson talks with Dr. Najeeb Al Hallak, the medical oncologist and co-leader of the gastrointestinal and neuroendocrine oncology multidisciplinary team at the Barbara Ann Karmanos Cancer Institute. They delve into the importance of early cancer screenings and how primary care physicians can play a pivotal role in early detection and prevention.

Main Points of Conversation:

  • The importance of early cancer screenings for young adults, especially for those with familial or genetic predispositions.
  • The impact of environmental and behavioral factors on cancer risk in younger populations.
  • Specific cancer screening recommendations for young adults, including colonoscopies, mammograms, and genetic testing.

Dr. Najeeb Al Hallak is a distinguished medical oncologist specializing in gastrointestinal cancers. He serves as an associate professor in oncology at Wayne State University and co-leads the gastrointestinal and neuroendocrine oncology multidisciplinary team at the Barbara Ann Karmanos Cancer Institute. His research focuses on gastrointestinal malignancies, clinical trials, and the development of new cancer treatments.

I Don't Care

Part of this channel

I Don't Care

Candid healthcare leadership conversations with Kevin Stevenson

Visit the channel

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

About the author

Kevin Stevenson
Kevin StevensonTop Hospital Administrator & Healthcare COO, I Don't Care

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Ambient AI is moving from clinician productivity to consent and revenue-cycle controls

Ambient AI is moving from clinician productivity to consent and revenue-cycle controls

Ambient artificial intelligence (AI) in healthcare is rapidly advancing from enhancing clinician productivity to broader applications in consent and revenue-cycle control. Hospitals must now manage the use of ambient documentation tools, such as microphones and AI models, with the same scrutiny as other operational technologies. This evolution underscores the growing importance of governing AI technologies in clinical settings to ensure compliance and effectiveness.

  • 01Hospitals are increasingly using ambient AI for tasks beyond clinician productivity, including managing consent and revenue cycles.
  • 02The deployment of ambient documentation requires hospitals to regulate microphones and AI models as strictly as other technologies.
  • 03The expansion of ambient AI in healthcare signifies a shift towards comprehensive governance of AI tools.

Aug 20, 2026

Connected Across Texas - Leah Barton

The article discusses healthcare connectivity efforts in Texas, focusing on Healthconnect TX's role. Connectivity is emphasized as crucial for efficient healthcare service delivery in the region.

  • 01Healthcare connectivity is vital for efficient service delivery.
  • 02Healthconnect TX is working to enhance healthcare connectivity in Texas.

Aug 18, 2026

Health tech AI investment is accelerating into chronic care, home health, and workforce training in 2026

Health tech AI investment is accelerating into chronic care, home health, and workforce training in 2026

Investment in health tech AI is increasing, with significant funding directed towards chronic care, home health, and workforce training. In June, there were four major funding rounds totaling $335 million aimed at improving these areas. The focus includes AI scheduling and home care operations.

  • 01Four major health tech funding rounds totaling $335 million were closed in June.
  • 02Investments are targeting chronic disease management, AI scheduling, and home care operations.
  • 03Workforce training in the healthcare sector is a key area receiving funding.

Aug 18, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

About the Experts

Kevin Stevenson
Kevin Stevenson

Host, I Don't Care Podcast

I Don't Care

Kevin Stevenson is the host of 'I Don't Care,' a MarketScale podcast focused on the challenges facing healthcare executives and administrators. He engages with industry leaders to explore the logistics and operational solutions that support hospitals, urgent care centers, and telemedicine operators. Stevenson holds an MBA and is a Fellow of the American College of Healthcare Executives (FACHE).

DN
Dr. Najeeb Al Hallak

Medical Oncologist and Co-Leader, Gastrointestinal and Neuroendocrine Oncology Multidisciplinary Team

Barbara Ann Karmanos Cancer Institute / Wayne State University

Dr. Najeeb Al Hallak is a medical oncologist specializing in gastrointestinal cancers and serves as an associate professor in oncology at Wayne State University. He co-leads the gastrointestinal and neuroendocrine oncology multidisciplinary team at the Barbara Ann Karmanos Cancer Institute. His research focuses on gastrointestinal malignancies, clinical trials, and the development of new cancer treatments.

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512